Cann Group Ltd. · ASX:CAN

Cann — Shareholder Meeting (October 2022)

28 slides from Cann's shareholder meeting presentation, Oct 25, 2022

  1. Slide 1: ASX Announcement: AGM Presentation

    ASX ANNOUNCEMENT 25 October 2022 AGM Presentation For personal use only 25 October 2022 – In advance of this morning’s Annual General Meeting of shareholders to be held at 10:00am, and in accordance with ASX Listing Rule 3.13.3, Cann Group Limited (CAN:ASX) is pleased to provide a copy of the presen

  2. Slide 2: Annual General Meeting

    For personal use only Annual General Meeting 25 October 2022 Cann Group Limited ABN 25 603 949 739

  3. Slide 3: Disclaimer | Important notice

    Disclaimer | Important notice This presentation (Presentation) has been prepared by Cann Group Limited (ABN 25 603 949 739) (Cann). For personal use only Summary information This Presentation contains summary information about Cann and its activities which is current as at the date of this Presentat

  4. Slide 4: Agenda

    Agenda Enhancing patients’ lives by For personal use only developing, producing and supplying Introduction innovative cannabis medicines. 1 Chairman’s Address 2 CEO’s Address 3 Q&A 4 Formal Business of AGM 5 Meeting Close 6 3 |

  5. Slide 5: General Meeting

    For personal use only 1 General Meeting 4

  6. Slide 6: Chairman's Address

    For personal use only 2 Chairman’s Address Mr Allan McCallum, AO 5

  7. Slide 7: Corporate Growth

    For personal use only Corporate Growth 6

  8. Slide 8: Market Growth

    For personal use only Market Growth 7

  9. Slide 9: Satipharm

    For personal use only Satipharm 8

  10. Slide 10: Share Purchase Plan

    For personal use only Share Purchase Plan 9

  11. Slide 11: Board and Management Changes

    For personal use only Board and Management Changes 10

  12. Slide 12: CEO's Address

    For personal use only 3 CEO’s Address Mr Peter Crock 11

  13. Slide 13: Mildura

    For personal use only Mildura 12

  14. Slide 14: Commercial Focus

    For personal use only Commercial Focus 13

  15. Slide 15: Satipharm

    For personal use only Satipharm 14

  16. Slide 16: Share Purchase Plan

    For personal use only Share Purchase Plan 15

  17. Slide 17: Outlook

    For personal use only Outlook 16

  18. Slide 18: This slide appears in place of a video

    For personal use only THIS SLIDE APPEARS IN PLACE OF A VIDEO

  19. Slide 19: Q&A

    For personal use only 4 Q&A 18

  20. Slide 20: Formal Business of AGM

    For personal use only 5 Formal Business of AGM 19

  21. Slide 21: Item | Financial statements and reports

    For personal use only Item 1 | Financial statements and reports To receive the financial report, directors’ report and auditor’s report for the Company and its controlled entities for the financial year ended 30 June 2022. 20 |

  22. Slide 22: Resolutions for Voting

    For personal use only 6 Resolutions for Voting 21

  23. Slide 23: Resolution | Adoption of the Remuneration Report

    For personal use only Resolution 1 | Adoption of the Remuneration Report That pursuant to and in accordance with section 250R(2) of the Corporations Act, the Remuneration Report for the financial year ending 30 June 2022 as set out in pages 28 to 35 (inclusive) of the Annual Report be adopted. Proxy

  24. Slide 24: Resolution | Re-election of Director

    For personal use only Resolution 2 | Re-election of Director That Mr Allan McCallum, AO, a Director who retires from office in accordance with ASX Listing Rule 14.4 and Rule 50.2 of the Company’s Constitution and being eligible for re-election, be re-elected a Director of the Company. Proxy votes To

  25. Slide 25: Resolution | Re-election of Director

    For personal use only Resolution 3 | Re-election of Director That Mr Robert Barnes, a Director who was appointed to fill a casual vacancy with Rule 49.1 of the Company’s Constitution until this Annual General Meeting in accordance with ASX Listing Rule 14.4 and being eligible for re-election, be re-

  26. Slide 26: Resolution | Ratification of prior issue of shares

    For personal use only Resolution 4 | Ratification of prior issue of shares That, for the purpose of Listing Rule 7.4, Shareholders ratify the prior issue of 254,687 ordinary shares issued to Commonwealth Scientific and Industrial Research Organisation as set out in the Explanatory Memorandum which a

  27. Slide 27: Resolution | Approval of additional 10% placement capacity

    Resolution 5 | Approval of additional 10% placement capacity for 12 months For personal use only That, for the purpose of Listing Rule 7.1A, approval is given for the issue of equity securities, as that term is defined in the Listing Rules, totalling up to 10% of the issued capital of the Company at

  28. Slide 28: Contact

    For personal use only Contact Peter Crock Chief Executive Officer peter.crock@canngrouplimited.com Deborah Ambrosini Chief Financial Officer deborah.ambrosini@canngrouplimited.com Rhys Cohen Senior Corporate Communications Manager rhys.cohen@canngrouplimited.com canngrouplimited.com | +61 3 9095 718

Cann Group — Shareholder Meeting (October 2022) on 6ix